NURO NeuroMetrix Inc
Price (delayed)
$4.4177
Market cap
$9.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.96
Enterprise value
$7.78M
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has
Highlights
NeuroMetrix's debt has shrunk by 55% YoY and by 25% QoQ
NURO's EPS is up by 37% YoY and by 13% QoQ
NURO's quick ratio is down by 12% year-on-year but it is up by 6% since the previous quarter
NeuroMetrix's gross profit has plunged by 57% YoY and by 23% from the previous quarter
NURO's revenue is down by 49% year-on-year and by 20% since the previous quarter
Key stats
What are the main financial stats of NURO
Market
Valuations
Earnings
Shares outstanding
2.06M
Market cap
$9.1M
Enterprise value
$7.78M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
2.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.56
Revenue
$3.03M
Gross profit
$1.68M
Operating income
-$8.78M
Net income
-$7.81M
EBIT
-$7.81M
EBITDA
-$7.57M
Free cash flow
-$7.13M
Per share
Balance sheet
Liquidity
EPS
-$3.96
EPS diluted
-$3.96
Free cash flow per share
-$3.62
Book value per share
$7.01
Revenue per share
$1.54
TBVPS
$7.78
Total assets
$15.32M
Total liabilities
$1.01M
Debt
$107,352
Equity
$14.31M
Working capital
$14M
Debt to equity
0.01
Current ratio
14.83
Quick ratio
13.12
Net debt/EBITDA
0.17
Margins
Efficiency
Dividend
EBITDA margin
-249.7%
Gross margin
55.4%
Net margin
-257.4%
Operating margin
-289.6%
Return on assets
-43.3%
Return on equity
-47.1%
Return on invested capital
-50.5%
Return on capital employed
-54.5%
Return on sales
-257.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NURO stock price
How has the NeuroMetrix stock price performed over time
Intraday
1.79%
1 week
0.15%
1 month
0.27%
1 year
23.75%
YTD
11.28%
QTD
-0.07%
Financial performance
How have NeuroMetrix's revenue and profit performed over time
Revenue
$3.03M
Gross profit
$1.68M
Operating income
-$8.78M
Net income
-$7.81M
Gross margin
55.4%
Net margin
-257.4%
NURO's operating margin has shrunk by 139% YoY and by 26% QoQ
NeuroMetrix's net margin has shrunk by 133% YoY and by 26% QoQ
NeuroMetrix's gross profit has plunged by 57% YoY and by 23% from the previous quarter
NURO's revenue is down by 49% year-on-year and by 20% since the previous quarter
Growth
What is NeuroMetrix's growth rate over time
Valuation
What is NeuroMetrix stock price valuation
P/E
N/A
P/B
0.63
P/S
2.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.56
NURO's EPS is up by 37% YoY and by 13% QoQ
The P/B is 37% below the 5-year quarterly average of 1.0 but 26% above the last 4 quarters average of 0.5
The equity has declined by 29% year-on-year and by 10% since the previous quarter
NURO's revenue is down by 49% year-on-year and by 20% since the previous quarter
The stock's price to sales (P/S) is 44% more than its last 4 quarters average of 2.0 and 37% more than its 5-year quarterly average of 2.1
Efficiency
How efficient is NeuroMetrix business performance
NURO's ROS has shrunk by 133% YoY and by 26% QoQ
The ROIC has plunged by 50% YoY and by 11% from the previous quarter
NeuroMetrix's ROE has plunged by 50% YoY and by 11% from the previous quarter
NURO's ROA is down by 48% YoY and by 10% from the previous quarter
Dividends
What is NURO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NURO.
Financial health
How did NeuroMetrix financials performed over time
NeuroMetrix's total assets has decreased by 28% YoY and by 11% QoQ
NURO's total liabilities is down by 24% YoY and by 16% QoQ
NeuroMetrix's debt is 99% lower than its equity
NeuroMetrix's debt has shrunk by 55% YoY and by 25% QoQ
The equity has declined by 29% year-on-year and by 10% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.